People who use psychedelics to self-treat depression and anxiety often arrive at that decision after being dissatisfied with standard mental health care. An analysis of 98 posts from online discussion threads revealed a four-stage decision-making process: first, frustration with conventional treatment; second, exploring limited information about psychedelic options; third, trial-and-error use despite safety uncertainties; and fourth, either continuing or stopping self-treatment. Those who continued adapted their practices over time. Decisions were guided by personal and peers' experiences rather than scientific evidence, and many avoided healthcare and official sources due to stigma and legal concerns. The findings suggest a need for user-informed decisional support to reduce harm.
Desperation for relief from persistent depression and anxiety, after standard treatments fail, shapes how people decide to self-treat with psychedelics. Analyzing 108 Reddit discussion threads, members who expressed desperation described a tipping point where worsening mental health and frustration with conventional care made relief feel urgent. This urgency led to rapid, unplanned self-treatment with psychedelics, often without researching options or using harm reduction, despite acknowledged risks. Some reported relief, while others linked worsening mental health to multiple desperation-driven decisions. These interpretations may inform clinical psychedelic models, where access is often granted after other treatments fail, and similar urgency may influence engagement and outcomes.